Global Facial Injectables Market By Overview
Facial Injectables Market is projected to grow from USD 12.5 Billion in 2020 to USD 29.23 Billion by 2030.
Facial injectables are the dermal fillers which are used to rejuvenate facial skin by reducing or eliminating wrinkles, raising scar depressions, and enhancing lips. Global trend of young as well as old individuals to become more conscious regarding their aesthetic appearance, various dermatology products and procedures across the world is going to increase the demand for facial injectables market. Furthermore, increasing shift from invasive to minimally invasive procedures and development in facial rejuvenation are expected to support the market growth over the forecast period. Facial injectables are also known as fillers which primarily used for rejuvenate facial skin by reducing or eliminating wrinkles, raising scar depressions, enhancing lips, and replacing soft-tissue volume loss through facial injections. Facial injectable fillers are products which include collagen, hyaluronic acid, and calcium hydroxyl apatite.
Global Facial Injectables Market By Drivers & Restraints
Market Dynamics:
Increasing preferences for non-surgical or minimally invasive procedures for facial rejuvenation is major factor driving growth of the global facial injectables market. In addition, rising supportive government and non-government initiatives and expenditure for development of pharmaceutical sector across the globe is expected to boost demand for facial injectables. This factor expected to spur growth of the global facial injectables market in near future. Increasing number of various cosmetic skin problems which include deep lines, scars, and wrinkles are factors supporting growth of the global facial injectables market. Changing lifestyle and rising disposable income across the globe are another factors fueling growth of the global facial injectables market. Furthermore, rising mid-age population across the globe along with increasing demand for facial injectables by mid age population due to especially this population are facing skin problems with skin such as wrinkles are expected to boost demand for facial injectables. This factor is expected to augment growth of the global facial injectables market in near future. For instance, in 2019, according to data published by The World Bank, world population of age between 15-65 is 4.87 Bn in 2015. Increasing advancements in facial injectables and rising number of research activities for development of novel facial injectables fillers are expected to fuel growth of the global facial injectables market over the forecast period. However, high cost and safety concern are some of the factors expected to hamper growth of the global market over the forecast period.
Global Facial Injectables Market By Segmentations & Regional Insights
This report segments the global facial injectables market on the basis of product type, application, end user, and region. On the basis of product type, the target market is classified into dermal fillers and anti-wrinkle injection. The dermal fillers segment type, is sub-segmented into hyaluronic acid fillers, collagen filler, and synthetic fillers. Also, the anti-wrinkle injection segment is sub-segmented into botulinum toxin A and poly-l-lactic acid (plla). Based on application, the target market is segmented into wrinkle reduction, facelift, lip enhancement, and others. On the basis of end user, the target market is classified into for hospitals, dermatology centers, beauty clinics, and others.
Regional Analysis:
For detailed understanding of market dynamics, the global facial injectables market is analyzed across key regions viz North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Each of these regions is analyzed on the basis of market findings across major countries in these regions for a macro-level understanding of the global market. In 2018, market in North America is expected to accounts for major revenue share as compared to others region. This is attributed to increasing aging population and higher demand for non-invasive aesthetic procedures in countries in the countries of the region. Asia Pacific market in anticipated to witness fastest growth in terms of revenue in the near future, owing to the trend of medical tourism and higher disposable income.
Key features of the study:
Prophecy Market Insights provides detailed analysis on facial injectables market in our report- Global Facial Injectables Market by product type, application, end-user, and region The report provides market size (US$ Mn) and compounded annual growth rate (%) for the forecast period: 2019 – 2029, considering 2018 as the actual year. The report also contains in-depth analysis about market drivers, restraints, opportunities, new product launches, product approval, ongoing trends, customers demand, and regional outlook. The report delivers competitive analysis about leading players in the global facial injectables market based on various parameters such as company overview, product portfolio, regional presence, financial performance, distribution strategies, key developments, marketing strategies, and future plans. The analysis from the report would acquaint the marketers and management authorities of companies to make the appropriate decision with respect to their future product launch, ongoing trends, market expansion, and marketing tactics used overall the globe. Various strategy matrices include in the report are PEST analysis, PORTER’s five forces analysis, and opportunity map analysis to analyze the facial injectables market.
Global Facial Injectables Market, By Product Type:
-
-
- Dermal fillers
-
- Hyaluronic acid fillers
- Collagen fillers
- Synthetic fillers
-
- Anti-wrinkle injection.
-
- Botulinum Toxin A
- Poly-L-lactic Acid
Global Facial Injectables Market, By Application:
-
-
- Wrinkle reduction
- Facelift
- Lip enhancement
- Various other applications.
-
Global Facial Injectables Market, By End-User:
- Hospitals
- Others
- Beauty clinics
- Dermatology centers
Global Facial Injectables Market, By Region:
- North America
- Middle East & Africa
- Middle East & Africa Facial Injectables Market, By Product Type
- Middle East & Africa Facial Injectables Market, By Application
- Middle East & Africa Facial Injectables Market, By End-User
- Middle East & Africa Facial Injectables Market, By Country
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Latin America Facial Injectables Market, By Product Type
- Latin America Facial Injectables Market, By Application
- Latin America Facial Injectables Market, By End-User
- Latin America Facial Injectables Market, By Country
- Brazil
- Mexico
- Rest of Latin America
- Asia Pacific
- Asia Pacific Facial Injectables Market, By Product Type
- Asia Pacific Facial Injectables Market, By Application
- Asia Pacific Facial Injectables Market, By End-User
- Asia Pacific Facial Injectables Market, By Country
- China
- India
- Japan
- South Korea
- RestofAsia Pacific
- Europe
- Europe Facial Injectables Market, By Product Type
- Europe Facial Injectables Market, By Application
- Europe Facial Injectables Market, By End-User
- Europe Facial Injectables Market, By Country
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- North America Facial Injectables Market, By Product Type
- North America Facial Injectables Market, By Application
- North America Facial Injectables Market, By End-User
- North America Facial Injectables Market, By Country
- U.S.
- Canada
- Middle East & Africa
Global Facial Injectables Market By Competitive Landscape & Key Players
Some of the prominent players operating in the global facial injectables market include Allergan plc, Galderma S.A., Bioform Medical, Inc., Bausch Health Companies Inc., (Valeant Pharmaceuticals), Medicis Aesthetics Holdings, Inc., Elastagen Pty Ltd., Merz Pharma GmbH, and AG and Co. KGaA. Technological advancements in the product as well as in manufacturing process, product launches, and strategic partnerships are some trends witnessed in the global facial injectables market. For instance, in 2018, Allergan Plc, a pharmaceutical company has announced a plans to acquire Elastagen Pty Ltd., which is an Australia-based medical company. The acquisition focuses on incorporating of Elastagen’s clinical stage Tropoelastin platform into its facial injectables portfolio. Key players are focusing on development of novel technologically advanced medical facial injectables is expected to boost demand for facial injectables. This factor expected to create tremendous opportunities for the global facial injectables market in near future.Various key players in the facial injectables market engaged in launching its product portfolio thereby expanding company’s presence in various countries. For instance, in January 2013, Allerganhas launched its next-generation hyaluronic acid (HA) dermal filler formulation, JUVEDERM XC in India. JUVEDERM XC is dermal fillers containing local anesthetic lidocaine to offer extra comfort to patients during the treatment. JUVEDERM XC has already got approval from U.S. Food and Drug Administration (FDA), in January 2010. After launch, company intended to market its product to physicians, cosmetologist, and dermal experts in India through series of comprehensive, hands-on training sessions. The global facial Injectables market has been segmented on the basis of product type, application, end user, and region.
Global Facial Injectables Market By Company Profile
- Allergan plc
- Galderma S.A.
- Bioform Medical, Inc.
- Bausch Health Companies Inc.
- Medicis Aesthetics Holdings, Inc.
- Merz Pharma GmbH
- Co. KGaA.
FAQs
Global Facial Injectables Market is segmented, By Product Type : Dermal Fillers (Hyaluronic Acid Fillers, Collagen Fillers, and Synthetic Fillers), Anti-wrinkle Injection (Botulinum Toxin A, and Poly-L-lactic Acid (PLLA), By Application :Wrinkle Reduction, Facelift, Lip Enhancement, and Others, and By End User :Hospitals, Dermatology Centers, Beauty Clinics, and Others.
Various key players in the facial injectables market engaged in launching its product portfolio thereby expanding company’s presence in various countries.
Key players operating in the global facial injectables market includes Allergan plc, Galderma S.A., Bioform Medical, Inc., Bausch Health Companies Inc. (Valeant Pharmaceuticals), Medicis Aesthetics Holdings, Inc., Merz Pharma GmbH, and Co. KGaA.
North America is expected to dominate the global facial injectable market over the forecast period.